NASDAQ:MOTS
Motus GI Holdings Inc. Stock News
$0.0910
-0.0174 (-16.01%)
At Close: May 21, 2024
Motus GI to Release Second Quarter Results and Provide a Business Update on August 11
04:05pm, Thursday, 21'st Jul 2022
FORT LAUDERDALE, Fla., July 21, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System in Hard-to-Prepare Patients Presented at Digestive Disease Week 2022
08:05pm, Tuesday, 24'th May 2022 GlobeNewswire Inc.
– The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of poor bowel preparation
HC Wainwright & Co. Maintains Buy Rating for Motus GI Hldgs: Here's What You Need To Know
04:03pm, Monday, 16'th May 2022 Benzinga
HC Wainwright & Co. has decided to maintain its Buy rating of Motus GI Hldgs (NASDAQ:MOTS) and lower its price target from $2.00 to $1.50.
Shares of Motus GI Hldgs are trading up 2.97% over the last 2
Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q1 2022 Results - Earnings Call Transcript
08:58pm, Thursday, 12'th May 2022
Motus GI Holdings, Inc. (NASDAQ:MOTS ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Garth Russell - Managing Director-LifeSci Advisors, LLC Tim Moran - Chief Executive
Motus GI Reports First Quarter 2022 Financial Results and Provides Business Update
08:05pm, Thursday, 12'th May 2022 GlobeNewswire Inc.
FORT LAUDERDALE, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve
AllScripts Healthcare (MDRX) Q1 Earnings and Revenues Lag Estimates
09:35pm, Thursday, 05'th May 2022 Zacks Investment Research
AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Motus GI Holdings, Inc. (MOTS) Report Negative Earnings Next Week? What You Should Know
07:00pm, Thursday, 05'th May 2022 Zacks Investment Research
Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Motus GI Holdings, Inc. (MOTS) Report Negative Earnings Next Week? What You Should Know
04:33pm, Thursday, 05'th May 2022
Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Motus GI to Release First Quarter Results and Provide a Business Update on May 12
08:00am, Thursday, 28'th Apr 2022
FORT LAUDERDALE, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve
Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q4 2021 Results - Earnings Call Transcript
10:51pm, Tuesday, 29'th Mar 2022
Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q4 2021 Results - Earnings Call Transcript
Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Misses Revenue Estimates
10:35pm, Tuesday, 29'th Mar 2022 Zacks Investment Research
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 0% and 27.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Misses Revenue Estimates
08:19pm, Tuesday, 29'th Mar 2022
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 0% and 27.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
08:05pm, Tuesday, 29'th Mar 2022 GlobeNewswire Inc.
FORT LAUDERDALE, Fla., March 29, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that impro
Strata Skin Sciences, Inc. (SSKN) Reports Q4 Loss, Tops Revenue Estimates
09:15pm, Monday, 21'st Mar 2022 Zacks Investment Research
Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of 33.33% and 0.83%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the
Motus GI to Release Fourth Quarter and Full Year 2021 Results and Provide a Business Update on March 29
08:05pm, Tuesday, 15'th Mar 2022 GlobeNewswire Inc.
FORT LAUDERDALE, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that impro
